UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR‐1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL. (June 2017)

• Record Type: Journal Article
• Authors: Davids, M.S.; Kim, H.T.; Nicotra, A.; Savell, A.; Francoeur, K.; Hellman, J.M.; Miskin, H.; Sportelli, P.; Bashey, A.; Stampleman, L.; Rueter, J.; Boruchov, A.; Arnason, J.E.; Jacobson, C.A.; Jacobsen, E.J.; Fisher, D.C.; Brown, J.R.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 54
• Page End: 55
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2437_39
• Languages: English
• ISSNs: 0278-0232